Phase response curve
A phase response curve (PRC) illustrates the transient change in the cycle period of an oscillation induced by a perturbation as a function of the phase at which it is received. PRCs are used in various fields; examples of biological oscillations are the heartbeat, circadian rhythms, and the regular, repetitive firing observed in some neurons in the absence of noise.
PRCs in circadian rhythms
In circadian rhythm research, a PRC illustrates the relationship between a treatment's time of administration and the treatment's effect on a circadian rhythm. Normally, the body's various physiological rhythms will be synchronized within an individual organism (human or animal). The sleep–wake cycle is the most familiar of these rhythms; for humans, a treatment designed to affect circadian rhythms will most often be intended to adjust sleep timing, by either delaying it to later in the day (night), or advancing it. Extreme morning people may want to delay their sleep timing; extreme evening chronotypes may wish to advance it.
A PRC is a graph showing, by convention, time of the subject's endogenous day along the x-axis and the amount of the phase shift (in hours) along the y-axis. The curve has one peak and one nadir in each 24 hour cycle. Relative circadian time is plotted vs. phase shift magnitude.
The two common treatments used to shift the timing of sleep are light therapy, directed at the eyes, and administration of the hormone melatonin, usually taken orally. Either or both can be used daily. Each of these treatments has its own PRC which will vary according to the species being studied; its shape may also vary individually, just slightly. The magnitude is dose-dependent. The discussions below are restricted to the human PRCs for the chronobiotics light and melatonin.
Starting about two hours before bedtime, exposure to[clarification needed] light will delay the circadian phase, causing later wake-up time and later sleep onset. The delaying effect gets stronger as evening progresses. About five hours after usual bedtime, coinciding with the body temperature nadir, the lowest point of the body temperature rhythm, the PRC peaks and the effect changes abruptly from phase delay to phase advance. Immediately after this peak, light exposure has its greatest phase-advancing effect, causing earlier wake-up and sleep onset. The effect diminishes until about two hours after spontaneous wake-up time, when it reaches zero. During the period between two hours after usual wake-up time and two hours before usual bedtime, bright light exposure has little or no effect on circadian phase (slight effects generally cancelling each other out).
Another image of the PRC for light is here (Figure 1).
Light therapy, typically with a light box producing 10,000 lux at a prescribed distance, can be used in the evening to delay or in the morning to advance a person's sleep timing. Because losing sleep to obtain bright light exposure is considered undesirable by most people, and because it is very difficult to estimate exactly when the greatest effect (the PRC peak) will occur in an individual, the treatment is usually applied just prior to bedtime (to achieve phase delay), or just after spontaneous awakening (to achieve phase advance).
In 2002 Brown University researchers led by David Berson announced the discovery of special cells in the human eye, ipRGCs (intrinsically photosensitive retinal ganglion cells), which many researchers now believe control the light entrainment effect of the phase response curve. In the human eye, the ipRGCs have the greatest response to light in the 460–480 nm (blue) range. In one experiment, 400 lux of blue light produced the same effects as 10,000 lux of white light. A theory of spectral opponency, in which the addition of other spectral colors renders blue light less effective for circadian phototransduction, was supported by research reported in 2005.
|This section does not cite any references or sources. (January 2014)|
The phase response curve for melatonin is roughly twelve hours out of phase with the phase response curve for light. At spontaneous wake-up time, exogenous (externally administered) melatonin has a slight phase-delaying effect. The amount of phase-delay increases until about eight hours after wake-up time, when the effect swings abruptly from strong phase delay to strong phase advance. The phase-advance effect diminishes as the day goes on until it reaches zero about bedtime. From usual bedtime until wake-up time, exogenous melatonin has no effect on circadian phase.
The human body produces its own (endogenous) melatonin starting about two hours before bedtime, provided the lighting is dim. This is known as dim-light melatonin onset, DLMO. This stimulates the phase-advance portion of the PRC and helps keep the body on a regular sleep-wake schedule. It also helps prepare the body for sleep.
Administration of melatonin at any time may have a mild hypnotic (sleep-inducing) effect. The resultant effect on sleep phase, if any, is governed by the PRC.
In a 2006 study Victoria L. Revell et al. showed that a combination of morning bright light and afternoon melatonin, both timed to phase advance according to the respective PRCs, produce a larger phase advance shift than bright light alone, for a total of up to 21⁄2 hours.
All times are approximate and vary from one person to another. In particular, there is no convenient way to accurately determine the times of the peaks and zero-crossings of these curves in an individual. Administration of light or melatonin close to the time at which the effect is expected to change sense abruptly may, if the changeover time is not accurately known, produce an opposite effect to that desired.
Origin of the PRC
The first published usage of the term "phase response curve" was in 1960 by Patricia DeCoursey. The "daily" activity rhythms of her flying squirrels, kept in constant darkness, responded to pulses of light exposure. The response varied according to the time of day—that is, the animals' subjective "day"—when light was administered. When DeCoursey plotted all her data relating the quantity and direction (advance or delay) of phase-shift on a single curve, she created the PRC. It has since been a standard tool in the study of biological rhythms.
PRC in neurons
Phase response curve analysis can be used to understand the intrinsic properties and oscillatory behavior of regular-spiking neurons. The neuronal PRCs can be classified as being purely positive (PRC type I) or as having negative parts (PRC type II). Importantly, the PRC type exhibited by a neuron is indicative of its input–output function (excitability) as well as synchronization behavior: networks of PRC type II neurons can synchronize their activity via mutual excitatory connections, but those of PRC type I can not.
Experimental estimation of PRC in living, regular-spiking neurons involves measuring the changes in inter-spike interval in response to a small perturbation, such as a transient pulse of current. Notably, the PRC of a neuron is not fixed but may change when firing frequency or neuromodulatory state of the neuron is changed.
- Carmen C. Canavier (2006). "Phase response curve". Scholarpedia 1 (12): 1332. doi:10.4249/scholarpedia.1332.
- Burgess HJ, Revell VL, Eastman CI (January 2008). "A three pulse phase response curve to three milligrams of melatonin in humans". J. Physiol. (Lond.) 586 (2): 639–647. doi:10.1113/jphysiol.2007.143180. PMC 2375577. PMID 18006583.
- Brown Scientists Uncover Inner Workings of Rare Eye Cells
- Glickman G, Byrne B, Pineda C, Hauck WW, Brainard GC (March 2006). "Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs)". Biol. Psychiatry 59 (6): 502–507. doi:10.1016/j.biopsych.2005.07.006. PMID 16165105.
- Figueiro MG, Bullough JD, Bierman A, Rea MS (October 2005). "Demonstration of additivity failure in human circadian phototransduction". Neuro Endocrinol. Lett. 26 (5): 493–8. PMID 16264413.
- Revell VL, Burgess HJ, Gazda CJ, Smith MR, Fogg LF, Eastman CI (January 2006). "Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light". J. Clin. Endocrinol. Metab. 91 (1): 54–59. doi:10.1210/jc.2005-1009. PMID 16263827.
- Zivkovic, Bora; aka "Coturnix" (2007). "Clock Tutorial #3c - Darwin On Time". A Blog Around the Clock. ScienceBlogs LLC. Archived from the original on 2005-01-06. Retrieved 2007-11-03. "[The PRC is] the single most important methodological tool in the study of all biological rhythms."
- Gutkin BS, Ermentrout GB, Reyes AD (August 2005). "Phase-response curves give the responses of neurons to transient inputs". J. Neurophysiol. 94 (2): 1623–1635. doi:10.1152/jn.00359.2004. PMID 15829595.
- Ermentrout B (July 1996). "Type I membranes, phase resetting curves, and synchrony". Neural Comput 8 (5): 979–1001. doi:10.1162/neco.19184.108.40.2069. PMID 8697231.
- Tsubo Y, Takada M, Reyes AD, Fukai T (June 2007). "Layer and frequency dependencies of phase response properties of pyramidal neurons in rat motor cortex". Eur. J. Neurosci. 25 (11): 3429–3441. doi:10.1111/j.1460-9568.2007.05579.x. PMID 17553012.
- Stiefel KM, Gutkin BS, Sejnowski TJ (2008). "Cholinergic neuromodulation changes phase response curve shape and type in cortical pyramidal neurons". In Ermentrout, Bard. PLoS ONE 3 (12): e3947. doi:10.1371/journal.pone.0003947. PMC 2596483. PMID 19079601.
- Rosenthal NE, Joseph-Vanderpool JR, Levendosky AA et al. (August 1990). "Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome". Sleep 13 (4): 354–61. PMID 2267478.
- Lewy A, Sack R, Fredrickson R (1983). "The use of bright light in the treatment of chronobiologic sleep and mood disorders: The phase-response curve". Psychopharmacol Bull 19: 523–5.
- Lewy AJ, Ahmed S, Latham JM et al. (1992). "Melatonin shifts human circadian rhythms according to a phase-response curve". Chronobiol Int. 9 (5): 380–392. doi:10.3109/07420529209064550. PMID 1394610.
- Figueiro MG, Rea MS (2010). "Lack of short-wavelength light during the school day delays dim light melatonin onset (DLMO) in middle school students". Neuro Endocrinol. Lett. 31 (1): 92–6. PMID 20150866.